Cambridge Centre for Naturally Randomized Trials: against COVID-19
COGENT (COvid-19 Genomic Evaluation of Novel Therapies) Research Group: Cardiovascular Epidemiology Unit Project Description: The COGENT (COvid-19 Genomic Evaluation of Novel Therapies) portfolio of studies is an international collaboration of investigators lead by the Centre for Naturally Randomized Trials at Cambridge that aims to conduct an integrated suite of studies that a) nests a series o...
COVID Labs/Universities
Technology
N/A
Founded
N/A
Employees
COVID R&D
Industry
Visual (Placeholder)
Profile Information
Name
Cambridge Centre for Naturally Randomized Trials: against COVID-19
Industry
COVID R&D
Technology
COVID Labs/Universities
Location
United Kingdom
Founded
N/A
Employees
N/A
Category
Hub
Contact Information
Website
N/A
Email
N/A
Phone
N/A
Address
N/A